ClinVar Miner

Submissions for variant NM_000038.6(APC):c.4913T>C (p.Met1638Thr) (rs201797422)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000213972 SCV000275885 likely benign Hereditary cancer-predisposing syndrome 2019-01-17 criteria provided, single submitter clinical testing In silico models in agreement (benign);Other strong data supporting benign classification
Illumina Clinical Services Laboratory,Illumina RCV000348692 SCV000452018 benign APC-Associated Polyposis Disorders 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Invitae RCV000549046 SCV000647546 uncertain significance Familial adenomatous polyposis 1 2019-12-18 criteria provided, single submitter clinical testing This sequence change replaces methionine with threonine at codon 1638 of the APC protein (p.Met1638Thr). The methionine residue is moderately conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is present in population databases (rs201797422, ExAC 0.01%). This variant has not been reported in the literature in individuals with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 231898). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Color RCV000213972 SCV000681695 uncertain significance Hereditary cancer-predisposing syndrome 2019-02-15 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000586239 SCV000694063 uncertain significance not provided 2017-05-15 criteria provided, single submitter clinical testing Variant summary: The APC c.4913T>C (p.Met1638Thr) variant involves the alteration of a conserved nucleotide located in the Adenomatous polyposis coli protein repeat region (InterPro). 2/4 in silico tools predict a benign outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 3/121374 control chromosomes, predominantly observed in the East Asian subpopulation at a frequency of 0.000116 (1/8654). This frequency is about 2 times the estimated maximal expected allele frequency of a pathogenic APC variant (0.0000714), suggesting this might be a benign polymorphism found primarily in the populations of East Asian origin. However, the allele number is very small. In addition, one other clinical diagnostic laboratory classified this variant as uncertain significance and another one classified it as Likely benign, all without evidence for independent evaluation. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.